Reversible Ototoxicity: A Rare Adverse Reaction of Liposomal Amphotericin-B Used for the Treatment of Antimony-Resistant Visceral Leishmaniasis in an Elderly Male

被引:2
|
作者
Das, P. C. [1 ]
Kandel, Ramesh [1 ]
Sikka, Kapil [2 ]
Dey, A. B. [1 ]
机构
[1] All India Inst Med Sci, Dept Geriatr Med, New Delhi, India
[2] All India Inst Med Sci, Dept ENT, New Delhi, India
关键词
liposomal Amphotericin-B; ototoxicity;
D O I
10.4137/CCRep.S15111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amphotericin-B, a broad spectrum antifungal agent, has been known to cause adverse effects such as nephrotoxicity and infusion-related side effects such as fever, chills, rigor, and arthralgias. However, ototoxicity as an adverse effect of Amphotericin-B has not yet been reported in medical literature. We here report a case of a reversible form of ototoxicity induced by liposomal Amphotericin-B (L-AmB).
引用
收藏
页码:63 / 66
页数:4
相关论文
共 13 条
  • [1] SUCCESSFUL TREATMENT OF ANTIMONY-RESISTANT CUTANEOUS LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B
    TORRECISNEROS, J
    PRADA, JL
    VILLANUEVA, JL
    VALVERDE, F
    SANCHEZGUIJO, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) : 1024 - 1025
  • [2] SUCCESSFUL TREATMENT OF ANTIMONY-RESISTANT VISCERAL LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B (L-AMPB-LRC) IN A CHILD
    KARANDE, SC
    BOBY, KFJ
    LAHIRI, KR
    JAIN, MK
    KSHIRSAGAR, NA
    GOKHALE, PC
    PANDYA, SK
    [J]. TROPICAL DOCTOR, 1995, 25 (02) : 80 - 81
  • [3] SUCCESSFUL TREATMENT OF ANTIMONY-RESISTANT VISCERAL LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    TORRECISNEROS, J
    VILLANUEVA, JL
    KINDELAN, JM
    JURADO, R
    SANCHEZGUIJO, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) : 625 - 627
  • [4] SUCCESSFUL TREATMENT OF RESISTANT VISCERAL LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B
    GOKHALE, PC
    KSHIRSAGAR, NA
    KHAN, MU
    PANDYA, SK
    MEISHERI, YV
    THAKUR, CP
    CHOUDHARY, CB
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (02) : 228 - 228
  • [5] LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS
    CROFT, SL
    DAVIDSON, RN
    THORNTON, EA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 111 - 118
  • [6] VISCERAL LEISHMANIASIS FOLLOWING TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B
    MCBRIDE, M
    LINNEY, M
    CLAYDON, EJ
    WEBER, J
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (02) : 362 - 362
  • [7] LIPOSOMAL AMPHOTERICIN-B IN DRUG-RESISTANT VISCERAL LEISHMANIASIS
    DAVIDSON, RN
    CROFT, SL
    SCOTT, A
    MAINI, M
    MOODY, AH
    BRYCESON, ADM
    [J]. LANCET, 1991, 337 (8749): : 1061 - 1062
  • [8] TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B OF A CHILD AFFECTED WITH DRUG-RESISTANT VISCERAL LEISHMANIASIS
    GIACCHINO, R
    GIAMBARTOLOMEI, G
    TASSO, L
    TIMITILLI, A
    CASTAGNOLA, E
    BRISIGOTTI, M
    MICALIZZI, C
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (03) : 310 - 310
  • [9] Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol
    Khodabandeh, Mahmoud
    Rostami, Ali
    Borhani, Katayoun
    Gamble, H. Ray
    Mohammadi, Mohsen
    [J]. PARASITOLOGY INTERNATIONAL, 2019, 72
  • [10] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS IN PATIENTS COINFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    TORRECISNEROS, J
    VILLANUEVA, JL
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 191 - 191